Said Moshawih | Pharmacology | Best Researcher Award

Published on by Health Scientists
Said Moshawih
Affiliation Al-Ahliyya Amman University
Country Jordan
Scopus ID 57209745538
Documents 42
Citations 998
h-index
17
Subject Area Pharmacology
Event Health Scientists Awards
ORCID 0000-0003-4840-0460

Best Researcher Award

Said Moshawih is an academic researcher specializing in pharmacology, medicinal plants, natural products, phytochemistry, pharmaceutical sciences, and evidence-based herbal medicine. His research integrates laboratory investigations with systematic scientific reviews to evaluate bioactive compounds, therapeutic mechanisms, and translational healthcare applications. His scholarly publications have contributed to understanding herbal pharmacology, cardiovascular protection, antimicrobial activities, antioxidant mechanisms, and functional medicinal plants while supporting innovation in pharmaceutical research and healthcare advancement.[1]

Abstract

Said Moshawih has established an internationally recognized research portfolio in pharmacology through multidisciplinary investigations involving medicinal plants, phytochemistry, pharmaceutical sciences, cardiovascular health, antimicrobial agents, antioxidant compounds, and evidence-based herbal medicine. His publications emphasize translating traditional medicinal knowledge into scientifically validated therapeutic applications while encouraging sustainable healthcare innovation. Through collaborations, systematic reviews, experimental pharmacology, and natural product research, his work has strengthened pharmaceutical development, improved understanding of bioactive compounds, supported clinical relevance, and contributed valuable scientific evidence for advancing modern healthcare practices and future pharmacological discoveries.[2]

Keywords

Medicinal plants, Pharmacology, Phytochemistry, Herbal medicine, Natural products, Antioxidants, Cardiovascular health, Antimicrobial activity, Ethnopharmacology, Functional foods, Bioactive compounds, Pharmaceutical sciences, Toxicology, Drug discovery, Plant extracts.

Introduction

Said Moshawih investigates medicinal plants and pharmaceutical sciences by integrating pharmacological evidence with phytochemical characterization. His research supports safe therapeutic development, explores natural bioactive compounds, and promotes evidence-based herbal medicine for improving disease prevention, healthcare quality, and future pharmaceutical innovation through multidisciplinary scientific collaboration worldwide.[3]

Research Profile

Said Moshawih maintains an active international research profile with publications spanning pharmacology, medicinal chemistry, pharmaceutical technology, herbal therapeutics, and systematic scientific reviews. His collaborative investigations have generated influential literature supporting translational medicine while encouraging innovation across academic, clinical, and pharmaceutical research environments globally.[1]

Research Contributions

Said Moshawih has contributed significantly to understanding phytochemicals, herbal pharmacology, antioxidant mechanisms, cardiovascular protection, antimicrobial compounds, and pharmaceutical formulations. His research strengthens scientific validation of medicinal plants while encouraging interdisciplinary collaborations that bridge laboratory discoveries with practical healthcare applications and therapeutic innovations.[4]

Publications

Said Moshawih has authored numerous highly cited publications covering medicinal plants, coriander pharmacology, herbal cardiovascular benefits, antimicrobial phytochemicals, colorectal cancer prevention, pharmaceutical sciences, and evidence-based natural medicine. These publications demonstrate sustained scholarly productivity, interdisciplinary collaboration, and consistent contributions to international scientific literature.[2]

Research Impact

Said Moshawih’s research has influenced pharmaceutical sciences by providing comprehensive evidence supporting medicinal plants and natural therapeutics. His publications receive substantial academic recognition through citations, demonstrating meaningful impact on pharmacological research, healthcare innovation, systematic reviews, and future evidence-based therapeutic development internationally.[1]

Award Suitability

Said Moshawih demonstrates strong qualifications for the Best Researcher Award through impactful publications, substantial citation performance, international collaborations, and continuous advancement of pharmacological knowledge. His scientific achievements reflect excellence in research quality, innovation, scholarly influence, and contributions benefiting healthcare and pharmaceutical sciences.[1]

Conclusion

Said Moshawih continues advancing pharmacology through innovative investigations involving medicinal plants, pharmaceutical sciences, and natural products. His sustained scholarly productivity, collaborative research, and evidence-based scientific contributions reinforce his reputation as a respected researcher supporting future developments in healthcare, therapeutic innovation, and pharmaceutical research worldwide.[2]

References

  1. Elsevier. (n.d.). Scopus Author Details: Said Moshawih, Author ID 57209745538. Scopus.
    https://www.scopus.com/pages/authors/57209745538
  2. ResearchGate. (n.d.). Research Profile of Said Moshawih.
    https://www.researchgate.net/profile/Said-Moshawih
  3. ORCID. Said Moshawih Research Profile.
    https://orcid.org/0000-0003-4840-0460
  4. Google Scholar. Said Moshawih Citation Profile.
    https://scholar.google.com/citations?user=_eqg7H4AAAAJ&hl=en&oi=ao
  5. Al-Ahliyya Amman University. Faculty Profile: Said Moshawih.
    https://www.ammanu.edu.jo/staff-directory/faculty-of-pharmacy/said-moshawih/

Maryam Tehranipour | Pharmacology | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Maryam Tehranipour | Pharmacology | Best Researcher Award

Animal Physiology | Islamic Azad University | Iran

Dr. Maryam Tehranipour is an accomplished Associate Professor in the Department of Biology at the Islamic Azad University, Mashhad, Iran, recognized for her distinguished contributions to the fields of diabetes, metabolic disorders, neurobiology, oxidative stress, and cancer biology. Holding a Ph.D. in Animal Physiology, she has built a dynamic academic and research career integrating cellular physiology, pharmacology, and molecular mechanisms of disease. Her extensive publication record spans a broad spectrum of biomedical investigations, including neuroprotective strategies, natural product pharmacology, nanomedicine, and experimental models of diabetes and neurodegeneration. Dr. Tehranipour’s pioneering studies have elucidated the roles of oxidative damage, angiogenesis, and neuronal regeneration in disease progression and therapeutic recovery, particularly highlighting the potential of bioactive compounds and nanocarrier systems in drug design and targeted therapy. Her collaborative work has advanced understanding of diabetic complications, nerve injury repair, and cancer cell modulation through natural and synthetic agents. Beyond her prolific research output, she has played a significant role in mentoring undergraduate, graduate, and doctoral students, fostering scientific rigor and innovation in physiological research. Her scholarly influence is reflected through her indexed publications, contributions to interdisciplinary research networks, and global collaborations that link physiology, biochemistry, and nanotechnology for translational health impact. Dr. Tehranipour’s scientific endeavors emphasize the integration of experimental biology with clinical relevance, aiming to bridge laboratory discoveries with therapeutic applications. Through her ongoing research, she continues to contribute meaningfully to global biomedical science, particularly in developing sustainable and biologically safe therapeutic interventions addressing chronic and degenerative diseases that pose major public health challenges. She has 238 citations from 53 documents with an h-index of 9.

Profile: Scopus 

Featured Publications

1. The Umbelliprenin-CTAB cellulose nanocrystal delivery system prevents hyperglycemia in diabetic rats by activating the insulin receptor IR/PDK1 pathway. (2025). Scientific Reports. Open access.

2. The effects of N-butanol and ethyl acetate fractions of Ferula asafoetida hydroalcoholic extract on the expression of VEGF and FGF genes in the chorioallantoic membrane of chick embryos. (2025). Journal of Veterinary Research.Open access.

3. Bimetallic-based colorimetric aptasensor for the quantitative analysis of ampicillin using catalytic activity of ZrFe metal–organic framework and terminal deoxynucleotidyl transferase-assisted signal amplification. (2025). Bionanoscience. Open access.

4. The effect of Ziziphora clinopodioides hydroalcoholic extract on the neuronal density and histopathology of the hippocampal area CA2 in streptozotocin-induced Alzheimer’s model in male rats. (2025). Journal of Chemical Health Risks. Open access.

5. A novel alpha-terpineol-loaded niosome formulation coated with hyaluronic acid and evaluation of its anticancer properties in vitro. (2025). Journal of Molecular Liquids. Open access.

Siyu Chen | Pharmacology | Best Researcher Award

Published on by Health Scientists

 Prof. Siyu Chen | Pharmacology | Best Researcher Award

Professor | China Pharmaceutical University | China

Dr. Chen Siyu currently serves as the Deputy Director of the Department of Biochemistry at the School of Life Sciences and Technology, China Pharmaceutical University, where he is also a Professor, Doctoral Supervisor, and Chief Young Scientist of the National Key Research and Development Program. He obtained his academic training in biochemistry and molecular biology, cultivating a strong foundation in metabolic and biochemical sciences. Dr. Chen’s research primarily focuses on Target Discovery and Intervention Strategies for Metabolic Diseases, aiming to elucidate molecular mechanisms and identify novel therapeutic targets for metabolic regulation. He has published extensively as first or corresponding author in leading international journals such as Advanced Science, Nature Communications, and Gut Microbes, with his work widely cited by peers. His innovative research has led to the granting of national patents and multiple ongoing patent applications. Dr. Chen has successfully led major research projects under national and provincial funding programs, including the National Key R&D Program for Young Scientists, the National Natural Science Foundation for Young Scientists, and the Jiangsu Province Excellent Youth Fund. Recognized for his scholarly excellence, he received the Outstanding Doctoral Dissertation Award of Jiangsu Province. In addition to his research, Dr. Chen contributes actively to the academic community as a Young Member of the Metabolism Committee of the Chinese Society of Biochemistry, Director of the Jiangsu Society of Developmental Biology, and Editorial Board Member of Journal of China Pharmaceutical University and Progress in Biochemistry and Biophysics. He also serves as a Guest Editor for Frontiers in Endocrinology and a regular reviewer for leading journals including Journal of Hepatology and ACS Nano. He has 1616 citations from 60 documents with an h-index of 24.

Profiles: Scopus | ORCID

Featured Publications

1. Photosensitive biomimetic nanomedicine-mediated recombination of adipose microenvironments for antiobesity therapy. (2025). Advanced Materials.

2. Wearable photobiomodulation halts thyroid cancer growth by leveraging thyroid photosensitivity. (2025). Bioengineering and Translational Medicine.

3. Blue light-driven cell cycle arrest in thyroid cancer via Retinal-OPN3 complex. (2024). Cell Communication and Signaling.

4. Luteolin detoxifies DEHP and prevents liver injury by degrading Uroc1 protein in mice. (2024). EMBO Molecular Medicine.

5. Rhodiolin inhibits the PI3K/AKT/mTOR signaling pathway via the glycolytic enzyme GPI in human papillary thyroid cancer. (2024). Phytomedicine.